HSD17B13 and metabolic dysfunction-associated steatohepatitis: The aim of our study was to investigate the effects of combining the risk factors PNPLA3, TM6SF2 and HSD17B13 on severity of NAFLD/NASH in a large cohort of patients from seven Central European tertiary care medical centers.